Cargando…

Prediction of resistance to chemotherapy in ovarian cancer: a systematic review

BACKGROUND: Patient response to chemotherapy for ovarian cancer is extremely heterogeneous and there are currently no tools to aid the prediction of sensitivity or resistance to chemotherapy and allow treatment stratification. Such a tool could greatly improve patient survival by identifying the mos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lloyd, Katherine L, Cree, Ian A, Savage, Richard S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371880/ https://www.ncbi.nlm.nih.gov/pubmed/25886033 http://dx.doi.org/10.1186/s12885-015-1101-8

Ejemplares similares

Mechanisms of chemotherapy resistance in ovarian cancer
por: Ortiz, Mylena, et al.
Publicado: (2022)

Predictive Value of HE4 in Platinum-Based Chemotherapy for Ovarian Cancer: A Systematic Review
por: Han, Yue, et al.
Publicado: (2021)

Biological Insights into Chemotherapy Resistance in Ovarian Cancer
por: Glasgow, Michelle A., et al.
Publicado: (2019)

Application of machine learning in prediction of Chemotherapy resistant of Ovarian Cancer based on Gut Microbiota
por: Gong, Ting-Ting, et al.
Publicado: (2021)

Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy
por: Glaysher, S, et al.
Publicado: (2010)

Chemotherapy Resistance in Advanced Ovarian Cancer Patients
por: Pokhriyal, Ruchika, et al.
Publicado: (2019)

Prediction of clinical response to drugs in ovarian cancer using the chemotherapy resistance test (CTR-test)
por: Kischkel, Frank Christian, et al.
Publicado: (2017)

Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer
por: O’Donnell, Timothy, et al.
Publicado: (2018)

CCNE1 Amplification as a Predictive Biomarker of Chemotherapy Resistance in Epithelial Ovarian Cancer
por: Gorski, Justin W., et al.
Publicado: (2020)

Bevacizumab in combination with chemotherapy for the treatment of advanced ovarian cancer: a systematic review
por: Aravantinos, Gerasimos, et al.
Publicado: (2014)

Preoperative albumin-to-fibrinogen ratio predicts chemotherapy resistance and prognosis in patients with advanced epithelial ovarian cancer
por: Yu, Wen, et al.
Publicado: (2019)

Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas
por: Österberg, Lovisa, et al.
Publicado: (2009)

Ovarian cancer resistance to PARPi and platinum-containing chemotherapy
por: Summey, Rebekah, et al.
Publicado: (2022)

ABCA1 is associated with the development of acquired chemotherapy resistance and predicts poor ovarian cancer outcome
por: Wang, Wanqi, et al.
Publicado: (2021)

Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies
por: Vasey, P A
Publicado: (2003)

Expression of resistance gene and prognosis of chemotherapy in primary epithelial ovarian cancer
por: Yang, Fengmei, et al.
Publicado: (2018)

Ovarian Reserve after Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis
por: Romito, Alessia, et al.
Publicado: (2021)

Bevacizumab combined with chemotherapy for ovarian cancer: A protocol for systematic review and meta-analysis
por: Liao, Ting, et al.
Publicado: (2021)

Effect of molecular targeted agents in chemotherapy for treating platinum-resistant recurrent ovarian cancer: A systematic review and meta-analysis
por: Liu, Luting, et al.
Publicado: (2021)

Involvement of non-coding RNAs in chemotherapy resistance of ovarian cancer
por: Shao, Yang, et al.
Publicado: (2018)

Molecular mechanisms of platinum-based chemotherapy resistance in ovarian cancer
por: Yang, Ling, et al.
Publicado: (2022)

Heterogeneous effects of cytotoxic chemotherapies for platinum-resistant ovarian cancer
por: Nara, Katsuhiko, et al.
Publicado: (2023)

Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy
por: Chan, Daniel L, et al.
Publicado: (2012)

Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance
por: Ricciardelli, Carmela, et al.
Publicado: (2017)

The clinicopathological significance of miR-1307 in chemotherapy resistant epithelial ovarian cancer
por: Zhou, Yingying, et al.
Publicado: (2015)

Fucosylated forms of alpha-1-antitrypsin that predict unresponsiveness to chemotherapy in ovarian cancer.
por: Thompson, S., et al.
Publicado: (1988)

Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy
por: Uno, Kaname, et al.
Publicado: (2022)

Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
por: Sharma, Sanjay, et al.
Publicado: (2003)

Reversal of Ovarian Cancer Cell Lines Multidrug Resistance Phenotype by the Association of Apiole with Chemotherapies
por: Afonso de Lima, Carolina, et al.
Publicado: (2020)

Ovarian Cancer Stemness: Biological and Clinical Implications for Metastasis and Chemotherapy Resistance
por: Motohara, Takeshi, et al.
Publicado: (2019)

Long Non-coding RNAs Involved in Resistance to Chemotherapy in Ovarian Cancer
por: Abildgaard, Cecilie, et al.
Publicado: (2020)

Low expression of NCALD is associated with chemotherapy resistance and poor prognosis in epithelial ovarian cancer
por: Feng, Li-yuan, et al.
Publicado: (2020)

LAMA3 DNA methylation and transcriptome changes associated with chemotherapy resistance in ovarian cancer
por: Feng, Li-yuan, et al.
Publicado: (2021)

Functional characterization of a novel transcript of ERCC1 in chemotherapy resistance of ovarian cancer
por: Liu, Jia, et al.
Publicado: (2017)

Bevacizumab combined with chemotherapy in platinum-resistant ovarian cancer: beyond the AURELIA trial
por: Lyon, Kristopher A., et al.
Publicado: (2020)

Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer
por: Stefanou, Dimitra T., et al.
Publicado: (2015)

Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review
por: Rizzo, Stefania, et al.
Publicado: (2022)

Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer
por: Ayub, Tiyasha H., et al.
Publicado: (2015)

FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy
por: Diaz Osterman, Carlos J, et al.
Publicado: (2019)

Chemotherapy of ovarian cancer in elderly patients
por: Troso-Sandoval, Tiffany A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_uvevgmt48d9fst42lacocm98op